Patent deposited for LevonanoIPF technology
We are pleased to announce the publication of the international patent application WO 2026/210556 A1, marking an important milestone in the development of the LEVONANO-IPF project.
This achievement represents a significant step towards the protection and valorization of the innovative technology developed within the project, supporting its potential translation into new therapeutic strategies for idiopathic pulmonary fibrosis.
The publication also opens new opportunities for technology transfer, industrial partnerships, and future collaborations aimed at advancing the preclinical development and pharmaceutical application of LEVONANO-IPF.







